Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 485

1.

Pulmonary resection in the treatment of 43 patients with well-localized, cavitary pulmonary multidrug-resistant tuberculosis in Shanghai.

Xie B, Yang Y, He W, Xie D, Jiang G.

Interact Cardiovasc Thorac Surg. 2013 Sep;17(3):455-9. doi: 10.1093/icvts/ivt251. Epub 2013 Jun 7.

2.

Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.

Park SK, Kim JH, Kang H, Cho JS, Smego RA Jr.

Int J Infect Dis. 2009 Mar;13(2):170-5. doi: 10.1016/j.ijid.2008.06.001. Epub 2008 Sep 2.

3.

Surgery increased the chance of cure in multi-drug resistant pulmonary tuberculosis.

Sung SW, Kang CH, Kim YT, Han SK, Shim YS, Kim JH.

Eur J Cardiothorac Surg. 1999 Aug;16(2):187-93.

PMID:
10485419
4.

Surgery offers high cure rates in multidrug-resistant tuberculosis.

Yaldiz S, Gursoy S, Ucvet A, Kaya SO.

Ann Thorac Cardiovasc Surg. 2011;17(2):143-7.

PMID:
21597410
5.

Surgical treatment for multidrug-resistant and extensive drug-resistant tuberculosis.

Kang MW, Kim HK, Choi YS, Kim K, Shim YM, Koh WJ, Kim J.

Ann Thorac Surg. 2010 May;89(5):1597-602. doi: 10.1016/j.athoracsur.2010.02.020.

PMID:
20417785
6.

Surgical treatment to increase the success rate of multidrug-resistant tuberculosis.

Man MA, Nicolau D.

Eur J Cardiothorac Surg. 2012 Jul;42(1):e9-12. doi: 10.1093/ejcts/ezs215. Epub 2012 Apr 24.

PMID:
22531273
7.

Pulmonary resection in the treatment of patients with pulmonary multidrug-resistant tuberculosis in Taiwan.

Chiang CY, Yu MC, Bai KJ, Suo J, Lin TP, Lee YC.

Int J Tuberc Lung Dis. 2001 Mar;5(3):272-7.

PMID:
11326827
8.

A retrospective study for the outcome of pulmonary resection in 49 patients with multidrug-resistant tuberculosis.

Park SK, Lee CM, Heu JP, Song SD.

Int J Tuberc Lung Dis. 2002 Feb;6(2):143-9.

PMID:
11931413
9.

Favorable outcomes for multidrug and extensively drug resistant tuberculosis patients undergoing surgery.

Vashakidze S, Gogishvili S, Nikolaishvili K, Dzidzikashvili N, Tukvadze N, Blumberg HM, Kempker RR.

Ann Thorac Surg. 2013 Jun;95(6):1892-8. doi: 10.1016/j.athoracsur.2013.03.067. Epub 2013 May 1.

10.

Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome.

Holtz TH, Sternberg M, Kammerer S, Laserson KF, Riekstina V, Zarovska E, Skripconoka V, Wells CD, Leimane V.

Ann Intern Med. 2006 May 2;144(9):650-9.

PMID:
16670134
11.

[Surgical treatment of multi-drug resistant pulmonary tuberculosis in 188 cases].

Li WT, Jiang GN, Gao W, Xiao HP, Ding JA.

Zhonghua Jie He He Hu Xi Za Zhi. 2006 Aug;29(8):524-6. Chinese.

PMID:
17074264
12.

Recurrence after successful treatment among patients with multidrug-resistant tuberculosis.

Lee J, Lim HJ, Cho YJ, Park YS, Lee SM, Yang SC, Yoo CG, Kim YW, Han SK, Yim JJ.

Int J Tuberc Lung Dis. 2011 Oct;15(10):1331-3. doi: 10.5588/ijtld.11.0098.

PMID:
22283890
13.

Current surgical intervention for pulmonary tuberculosis.

Takeda S, Maeda H, Hayakawa M, Sawabata N, Maekura R.

Ann Thorac Surg. 2005 Mar;79(3):959-63.

PMID:
15734413
14.

Resectional surgery combined with chemotherapy remains the treatment of choice for multidrug-resistant tuberculosis.

Shiraishi Y, Nakajima Y, Katsuragi N, Kurai M, Takahashi N.

J Thorac Cardiovasc Surg. 2004 Oct;128(4):523-8.

15.

Pulmonary resection for multidrug-resistant tuberculosis: the Israeli experience (1998-2011).

Papiashvili M, Barmd I, Sasson L, Lidji M, Litman K, Hendler A, Polanski V, Treizer L, Bendayan D.

Isr Med Assoc J. 2012 Dec;14(12):733-6.

16.
17.

Rapid impact of effective treatment on transmission of multidrug-resistant tuberculosis.

Dharmadhikari AS, Mphahlele M, Venter K, Stoltz A, Mathebula R, Masotla T, van der Walt M, Pagano M, Jensen P, Nardell E.

Int J Tuberc Lung Dis. 2014 Sep;18(9):1019-25. doi: 10.5588/ijtld.13.0834.

18.

The impact of expanded testing for multidrug resistant tuberculosis using genotype [correction of geontype] MTBDRplus in South Africa: an observational cohort study.

Hanrahan CF, Dorman SE, Erasmus L, Koornhof H, Coetzee G, Golub JE.

PLoS One. 2012;7(11):e49898. doi: 10.1371/journal.pone.0049898. Epub 2012 Nov 30. Erratum in: PLoS One. 2013;8(6). doi: 10.1371/annotation/47420ec0-db00-4994-a0de-86b5e5d713f4.

19.

Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.

Kwon YS, Kim YH, Suh GY, Chung MP, Kim H, Kwon OJ, Choi YS, Kim K, Kim J, Shim YM, Koh WJ.

Clin Infect Dis. 2008 Aug 15;47(4):496-502. doi: 10.1086/590005.

20.

Correlates of treatment outcomes and drug resistance among pulmonary tuberculosis patients attending tertiary care hospitals of Kolkata, India.

Goswami A, Chakraborty U, Mahapatra T, Mahapatra S, Mukherjee T, Das S, Das A, Dey SK, Ray S, Bhattacharya B, Pal NK.

PLoS One. 2014 Oct 7;9(10):e109563. doi: 10.1371/journal.pone.0109563. eCollection 2014.

Items per page

Supplemental Content

Write to the Help Desk